Home / Resource Library / Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States

Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States

Article estimating the cost of CLL treatment will rise by 590% to the price oral immunotherapies.